BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Castro J, Ocampo Y, Franco L. Cape Gooseberry [Physalis peruviana L.] Calyces Ameliorate TNBS Acid-induced Colitis in Rats. J Crohns Colitis. 2015;9:1004-1015. [PMID: 26221001 DOI: 10.1093/ecco-jcc/jjv132] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Khare T, Palakurthi SS, Shah BM, Palakurthi S, Khare S. Natural Product-Based Nanomedicine in Treatment of Inflammatory Bowel Disease. Int J Mol Sci 2020;21:E3956. [PMID: 32486445 DOI: 10.3390/ijms21113956] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
2 Ramadan MF. Bioactive Phytochemicals of Cape Gooseberry (Physalis peruviana L.). In: Murthy HN, Bapat VA, editors. Bioactive Compounds in Underutilized Fruits and Nuts. Cham: Springer International Publishing; 2019. pp. 1-16. [DOI: 10.1007/978-3-030-06120-3_3-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Karthikeyan A, Young KN, Moniruzzaman M, Beyene AM, Do K, Kalaiselvi S, Min T. Curcumin and Its Modified Formulations on Inflammatory Bowel Disease (IBD): The Story So Far and Future Outlook. Pharmaceutics 2021;13:484. [PMID: 33918207 DOI: 10.3390/pharmaceutics13040484] [Reference Citation Analysis]
4 Park HA, Kwon OK, Ryu HW, Min JH, Park MW, Park MH, Paik JH, Choi S, Paryanto I, Yuniato P, Oh SR, Ahn KS, Lee JW. Physalis peruviana L. inhibits ovalbumin‑induced airway inflammation by attenuating the activation of NF‑κB and inflammatory molecules. Int J Mol Med 2019;43:1830-8. [PMID: 30816433 DOI: 10.3892/ijmm.2019.4110] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
5 Acar A. Ameliorative effects of cape gooseberry (Physalis peruviana L.) against monosodium glutamate (MSG)–induced toxicity: genetic and biochemical approach. Environ Sci Pollut Res 2021;28:18035-49. [DOI: 10.1007/s11356-020-11800-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Taghipour YD, Bahramsoltani R, Marques AM, Naseri R, Rahimi R, Haratipour P, Iranpanah A, Panah AI, Farzaei MH, Abdollahi M. A systematic review of nano formulation of natural products for the treatment of inflammatory bowel disease: drug delivery and pharmacological targets. Daru 2018;26:229-39. [PMID: 30382546 DOI: 10.1007/s40199-018-0222-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
7 Uribe E, Gómez-pérez LS, Pasten A, Pardo C, Puente L, Vega-galvez A. Assessment of refractive window drying of physalis (Physalis peruviana L.) puree at different temperatures: drying kinetic prediction and retention of bioactive components. Food Measure. [DOI: 10.1007/s11694-022-01373-7] [Reference Citation Analysis]
8 Lin Y, Liu H, Bu L, Chen C, Ye X. Review of the Effects and Mechanism of Curcumin in the Treatment of Inflammatory Bowel Disease. Front Pharmacol 2022;13:908077. [DOI: 10.3389/fphar.2022.908077] [Reference Citation Analysis]
9 Kasali FM, Tuyiringire N, Peter EL, . Ahovegbe LY, Ali MS, Tusiimire J, Ogwang PE, Kadima JN, Agaba AG. Chemical constituents and evidence-based pharmacological properties of Physalis peruviana L.: An overview. J Herbmed Pharmacol 2022;11:35-47. [DOI: 10.34172/jhp.2022.04] [Reference Citation Analysis]
10 Farzaei MH, El-senduny FF, Momtaz S, Parvizi F, Iranpanah A, Tewari D, Naseri R, Abdolghaffari AH, Rezaei N. An update on dietary consideration in inflammatory bowel disease: anthocyanins and more. Expert Review of Gastroenterology & Hepatology 2018;12:1007-24. [DOI: 10.1080/17474124.2018.1513322] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
11 Medina S, Collado-gonzález J, Ferreres F, Londoño-londoño J, Jiménez-cartagena C, Guy A, Durand T, Galano J, Gil-izquierdo Á. Potential of Physalis peruviana calyces as a low-cost valuable resource of phytoprostanes and phenolic compounds: Phytoprostanes and phenolic compounds in Physalis peruviana residues. J Sci Food Agric 2019;99:2194-204. [DOI: 10.1002/jsfa.9413] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
12 Ge F, Zhu S, Liu L, Yan J, Ji Y, Sun Z. Anti-inflammatory effects of Fagopyrum cymosum administered as a potential drug for ulcerative colitis. Exp Ther Med 2017;14:4745-54. [PMID: 29201175 DOI: 10.3892/etm.2017.5153] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
13 Bazana MT, da Silva SS, Codevilla CF, de Deus C, Lucas BN, Ugalde GA, Mazutti MA, Moraes Flores EM, Barin JS, de Bona da Silva C, de Menezes CR. Development of nanoemulsions containing Physalis peruviana calyx extract: A study on stability and antioxidant capacity. Food Res Int 2019;125:108645. [PMID: 31554039 DOI: 10.1016/j.foodres.2019.108645] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Shepherd C, Giacomin P, Navarro S, Miller C, Loukas A, Wangchuk P. A medicinal plant compound, capnoidine, prevents the onset of inflammation in a mouse model of colitis. Journal of Ethnopharmacology 2018;211:17-28. [DOI: 10.1016/j.jep.2017.09.024] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
15 Kamalian A, Sohrabi Asl M, Dolatshahi M, Afshari K, Shamshiri S, Momeni Roudsari N, Momtaz S, Rahimi R, Abdollahi M, Abdolghaffari AH. Interventions of natural and synthetic agents in inflammatory bowel disease, modulation of nitric oxide pathways. World J Gastroenterol 2020; 26(24): 3365-3400 [PMID: 32655263 DOI: 10.3748/wjg.v26.i24.3365] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
16 Nocetti D, Núñez H, Puente L, Espinosa A, Romero F. Composition and biological effects of goldenberry byproducts: an overview. J Sci Food Agric 2020;100:4335-46. [DOI: 10.1002/jsfa.10386] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
17 Ocampo YC, Caro DC, Rivera DE, Franco LA. Safety of sucrose esters from Physalis peruviana L. in a 28-day repeated-dose study in mice. Biomedicine & Pharmacotherapy 2017;90:850-62. [DOI: 10.1016/j.biopha.2017.04.046] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]